Daniel Bondeson to Fusion Proteins, bcr-abl
This is a "connection" page, showing publications Daniel Bondeson has written about Fusion Proteins, bcr-abl.
Connection Strength
0.334
-
Burslem GM, Bondeson DP, Crews CM. Scaffold hopping enables direct access to more potent PROTACs with in vivo activity. Chem Commun (Camb). 2020 Jun 23; 56(50):6890-6892.
Score: 0.173
-
Burslem GM, Schultz AR, Bondeson DP, Eide CA, Savage Stevens SL, Druker BJ, Crews CM. Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-Mediated Targeted Protein Degradation. Cancer Res. 2019 09 15; 79(18):4744-4753.
Score: 0.162